Technical Articles

Interleukin-1
IL-33：能否成为下一代肿瘤免疫治疗的新靶点？
IL-33: Can It Become the Next Target for Tumor Immunotherapy?
发布时间 2025-09-16
IL-33 is a member of the interleukin-1 cytokine family, initially named DVS27. It is constitutively expressed in barrier tissue cells of various organs, and its specific receptor is suppression of tumorigenicity 2 (ST2).
View details
  • Cancer
  • IL-33
  • tumor immunotherapy
  • Interleukin-1
Total 1
  • 1
Go to
UA
Link：
Products
Application
Cell FactorTarget Proteins
Custom Services
Custom Protein Expression ServicesCustom SPR Services
About Us
PromotionTechnical ArticlesProduct ApplicationFAQsCitationsAbout Us
We Media：
Facebook Linkedin YouTube X Thraeds Pinterest
©2021-2026 all rights reserved UA Biotechnology Co.,Ltd.
Privacy Policy
网站备案号 浙ICP备2022019033号-2 浙公网安备33010202004867号
 Business license (three certificates in one)
Tel：+86-25-56221161
E-mail：order@ua-bio.com
All products sold on this website shall not be used for clinical diagnosis or treatment of humans or animals, and shall only be used for non-medical purposes such as industrial or scientific research.